Lakshay Sahni and Ramya Yellapragada work in a part of healthcare that remains limited in access. At 28, they are the Co-founders of Marbles Health, a neurotechnology company focused on non-invasive brain care. The company builds medical systems that support treatment for mental and neurological conditions.

Marbles Health operates under Neuracle Health Private Limited. It works with hospitals and psychiatrists to provide neuromodulation as part of clinical care. The company began operations in 2020.

A Shared Problem in Brain Care

Both founders saw gaps in how brain health gets treated. Patients often move between diagnoses, medicines and therapy without clear outcomes. Many treatments focus on symptom control.

Ramya Yellapragada trained in computer science. She later studied neuroscience and computational biology. She wanted to work on solutions that reach patients rather than stay limited to research.

Lakshay Sahni studied electronics engineering at Delhi Technological University. His early work focused on brain-inspired computing and neural systems. He wanted to build full medical solutions rather than isolated research tools.

They met during the RISE Bhattacharya Tech Leaders Fellowship in 2019. Their work shifted from research to applied healthcare.

Founding Marbles Health

In 2020, the founders incorporated Neuracle Health Private Limited. Marbles Health became the operating brand. The company chose neuromodulation as its focus.

Neuromodulation uses controlled electrical signals to influence brain activity. It does not replace medication or therapy. It supports them.

The founders saw this approach as scalable and safe when used under medical supervision.

The EASE Device

Marbles Health developed EASE, a portable neuromodulation system. EASE is India’s first medically licensed device in this category.

The device delivers non-invasive brain stimulation. It also includes EEG monitoring and structured cognitive tasks. Doctors use it in clinics and supervised home care.

Large neuromodulation machines often cost over ₹1.5 crore and stay limited to hospitals. EASE costs less and fits into regular psychiatric workflows.

This design allows more patients to access care.

Clinical Use and Reach

After receiving regulatory approvals in 2024, Marbles Health began deployment. Hospitals now use EASE for supervised treatment.

Institutions using the system include AIIMS, CIP Ranchi and KMC Manipal. More than 3,000 patient sessions have taken place so far.

Doctors use EASE for conditions such as depression, anxiety, addiction, OCD and ADHD. Research also continues in stroke recovery and tumour rehabilitation.

The company tracks outcomes through standard clinical assessments.

Evidence-First Approach

Marbles Health places strong focus on clinical evidence. The founders believe neuromodulation needs strict protocols.

Each treatment follows defined dosage and frequency rules. Doctors assess patients before and after sessions. This helps measure progress.

Much of the company’s work lies in treatment design rather than hardware alone.

Business Model and Operations

Marbles Health follows a B2B model. It works with hospitals and psychiatrists. Doctors prescribe neuromodulation as part of a wider treatment plan.

The company also supports supervised home care. Patients receive care under medical guidance.

This approach keeps the system within clinical boundaries.

Research and Expansion

The company runs parallel research in mental health and neurorehabilitation. Areas include depression, anxiety and post-stroke recovery.

The founders plan broader clinical studies. They also plan regulatory expansion to support wider use.

Growth will stay tied to evidence and approval.

Investor View

Early investors supported the company based on clarity of purpose. They saw neuromodulation as a method with wide application.

The founders remain focused on long-term healthcare impact rather than quick scale.

A Measured Path in Healthcare

Brain care remains complex. Marbles Health does not claim quick fixes. It adds one more clinical tool.

Lakshay Sahni and Ramya Yellapragada continue to build with caution. Their aim is access, safety and proof.

Their work shows how technology can support care without replacing doctors.

FAQs

Q1. Who are Lakshay Sahni and Ramya Yellapragada?
They are Indian healthcare entrepreneurs and the Co-founders of Marbles Health.

Q2. What does Marbles Health do?
Marbles Health develops non-invasive neuromodulation systems used in mental and neurological care.

Q3. What is EASE by Marbles Health?
EASE is India’s first medically licensed portable neuromodulation device for clinical use.

Q4. Why is Marbles Health in the news?
The company has deployed its device in major hospitals and is expanding research in brain care.